This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rich, J. N. Search for Related Content PubMed PubMed Citation Articles by Rich, J. N. Related Collections Cellular Pathobiology Cellular Pathobiology: DNA Damage and Stress Responses

Cancer Stem Cells in Radiation Resistance

Departments of Medicine, Pharmacology and Cancer Biology, and Surgery, Duke University Medical Center, Durham, North Carolina

Requests for reprints: Jeremy N. Rich, Division of Neurology, Duke University Medical Center, P. O. Box 2900, Durham, NC 27710. Phone: 919-681-1693; Fax: 919-684-6514; E-mail: rich0001{at}mc.duke.edu.

Highly tumorigenic subpopulations of several solid cancers share characteristics with somatic stem cells. We showed recently that cancer stem cells, or tumor-initiating cells, derived from human glioblastoma surgical specimens and xenografts display resistance to radiation due to increased activation of the DNA damage checkpoint. We additionally showed that these same tumor subpopulations promote tumor angiogenesis through increased expression of vascular endothelial growth factor. These studies and subsequent reports from other researchers support critical roles for cancer stem cells in determining tumor response to therapy. Hypoxia and stem cell maintenance pathways may provide therapeutic targets to sensitize cancer stem cells to cytotoxic therapies to improve cancer patient treatments. [Cancer Res 2007;67(19):8980–4]

This article has been cited by other articles:

				G. Frosina DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy Mol. Cancer Res., July 1, 2009; 7(7): 989 - 999. [Abstract] [Full Text] [PDF]

				H. TANAKA, M. NAKAMURA, C. KAMEDA, M. KUBO, N. SATO, S. KUROKI, M. TANAKA, and M. KATANO The Hedgehog Signaling Pathway Plays an Essential Role in Maintaining the CD44+CD24-/low Subpopulation and the Side Population of Breast Cancer Cells Anticancer Res, June 1, 2009; 29(6): 2147 - 2157. [Abstract] [Full Text] [PDF]

				J.-P. Kilday, R. Rahman, S. Dyer, L. Ridley, J. Lowe, B. Coyle, and R. Grundy Pediatric Ependymoma: Biological Perspectives Mol. Cancer Res., June 1, 2009; 7(6): 765 - 786. [Abstract] [Full Text] [PDF]

				W. Zhuang, Z. Qin, and Z. Liang The role of autophagy in sensitizing malignant glioma cells to radiation therapy Acta Biochim Biophys Sin, May 1, 2009; 41(5): 341 - 351. [Abstract] [Full Text] [PDF]

				T. W. Abel, C. Clark, B. Bierie, A. Chytil, M. Aakre, A. Gorska, and H. L. Moses GFAP-Cre-Mediated Activation of Oncogenic K-ras Results in Expansion of the Subventricular Zone and Infiltrating Glioma Mol. Cancer Res., May 1, 2009; 7(5): 645 - 653. [Abstract] [Full Text] [PDF]

				A. Gurung, F. Uddin, R. P. Hill, P. C. Ferguson, and B. A. Alman {beta}-Catenin Is a Mediator of the Response of Fibroblasts to Irradiation Am. J. Pathol., January 1, 2009; 174(1): 248 - 255. [Abstract] [Full Text] [PDF]

				M. A. Harris, H. Yang, B. E. Low, J. Mukherje, A. Guha, R. T. Bronson, L. D. Shultz, M. A. Israel, and K. Yun Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma Cancer Res., December 15, 2008; 68(24): 10051 - 10059. [Abstract] [Full Text] [PDF]

				S. Sell and H. L. Leffert Liver Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2800 - 2805. [Abstract] [Full Text] [PDF]

				L. S. Hart and W. S. El-Deiry Invincible, but Not Invisible: Imaging Approaches Toward In Vivo Detection of Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2901 - 2910. [Abstract] [Full Text] [PDF]